Skip to content

A study to compare telecounselling and in person genetic counselling for ovarian cancer cases of AIIMS

Comparison of the impact of telegenetics and in-person genetic counselling on patient satisfaction and acceptance of genetic testing in women with Epithelial Ovarian Cancer - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061036
Enrollment
160
Registered
2024-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

Intervention1: Face-to-face genetic counselling: All cases diagnosed with ovarian cancer will undergo genetic counselling of 40-60minutes. Control Intervention1: Telegentics: Another group diagnosed w

Sponsors

DR SUVIDYA SINGH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All women with epithelial ovarian cancer, Recurrent ovarian cancer, Willing to participate

Exclusion criteria

Exclusion criteria: Non epithelial ovarian cancer,Patients not having access to internet and WhatsApp application in smart phone, Previous genetic counselling or genetic testing, All women with inadequate proficiency with Hindi/English language.

Design outcomes

Primary

MeasureTime frame
To compare acceptance for undergoing genetic testing in women with EOC, undergoing tele-genetics versus in-person genetic counselling by clinical team. To compare the satisfaction of women with EOC undergoing tele-genetics versus in-person genetic counselling by clinical team, using the mean genetic counselling satisfaction score (GCSS). Timepoint: Will be recorded 1 week after genetic counselling session

Secondary

MeasureTime frame
1. To assess the Knowledge & attitude of women with EOC regarding genetic testing 2. To compare the attendance of genetic counselling in telegenetics vs in-person genetic counselling 3. To assess the impact of factors leading to delay in seeking medical care in these patients on acceptance of genetic testing 4. To assess the barriers towards genetic testing in women with EOC 5. Comparison of time taken in each group & number of visits/sessions in each arm Timepoint: After 1 week of genetic counselling

Countries

India

Contacts

Public ContactDr Seema Singhal

AIIMS, NEW DELHI

drseemasinghal@gmail.com09818291001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026